Supplemental Digital Content is available in the text.
Keywords: blood pressure, cerebral autoregulation, cerebral blood flow, cerebral hemodynamics, intracranial pressure, mathematical modeling
Abstract
Objectives:
Time-averaged intracranial pressure-to-blood pressure Fisher-transformed Pearson correlation (PRx) is used to assess cerebral autoregulation and derive optimal cerebral perfusion pressure. Empirically, impaired cerebral autoregulation is considered present when PRx is positive; greater difference between time series median cerebral perfusion pressure and optimal cerebral perfusion pressure (ΔCPP) is associated with worse outcomes. Our aims are to better understand: 1) the potential strategies for targeting optimal cerebral perfusion pressure; 2) the relationship between cerebral autoregulation and PRx; and 3) the determinants of greater ΔCPP.
Design:
Mechanistic simulation using a lumped compartmental model of blood pressure, intracranial pressure, cerebral autoregulation, cerebral blood volume, Paco2, and cerebral blood flow.
Setting:
University critical care integrative modeling and precision physiology research group.
Subjects:
None, in silico studies.
Interventions:
Simulations in blood pressure, intracranial pressure, Paco2, and impairment of cerebral autoregulation, with examination of “output” cerebral perfusion pressure versus PRx-plots, optimal cerebral perfusion pressure, and ΔCPP.
Measurements and Main Results:
In regard to targeting optimal cerebral perfusion pressure, a shift in mean blood pressure or mean intracranial pressure with no change in mean blood pressure, with intact cerebral autoregulation, impacts optimal cerebral perfusion pressure. Second, a positive PRx occurs even with intact cerebral autoregulation. In relation to ΔCPP, for a given input blood pressure profile, with constant intracranial pressure, altering the degree of impairment in cerebral autoregulation or the level of Paco2 maintains differences to within ±5 mm Hg. Change in intracranial pressure due to either an intermittently prolonged pattern of raised intracranial pressure or terminal escalation shows ΔCPP greater than 10 mm Hg and less than –10 mm Hg, respectively.
Conclusions:
These mechanistic simulations provide insight into the empiric basis of optimal cerebral perfusion pressure and the significance of PRx and ΔCPP. PRx and optimal cerebral perfusion pressure deviations do not directly reflect changes in cerebral autoregulation but are, in general, related to the presence of complex states involving well-described clinical progressions with raised intracranial pressure.
A key concern in the management of patients with severe traumatic brain injury (TBI) is whether cerebral autoregulation (CA) is intact and able to minimize alterations in cerebral blood flow (CBF) due to changes in cerebral perfusion (1–3). Because there are a number of processes underlying CA and CBF control, we have two main clinical challenges to consider: variance in the upper and lower limits of CA, and not knowing patient-specific optimal levels in intrinsic physiologic factors such as Paco2, blood pressure (BP), and intracranial pressure (ICP) (4–6).
These are two general approaches studying indirectly whole brain circulation pathophysiology (6). First, an empirical approach using observational and epidemiologic evidence to establish statistical relationships and correlations between inputs and outputs. This approach is best exemplified by studies in severe TBI using ICP to BP Fisher-transformed Pearson correlation (“PRx”) (i.e., 5–7 min of time-averaged ICP and BP data to calculate mean Fisher-transformed Pearson correlation) to derive, by statistical analyses, the cerebral perfusion pressure (CPP, the difference between mean BP and mean ICP) optimal for an individual (i.e., optimal CPP [CPPOpt]). Briefly, by inference, because positive PRx is considered representative of disturbed CA and negative PRx is reflective of intact CA (7), the CPPOpt is defined as the CPP at which PRx is at its minimum (7–10). In severe TBI, the difference between contemporaneous time series median CPP (CPPMed) and CPPOpt (i.e., difference between time series CPPMed and CPPOpt [ΔCPP]) 0–5 mm Hg is associated with favorable outcome, whereas ΔCPP –10 to –15 mm Hg occurs only in those with unfavorable outcome (8). Such empiric associations can lead to new hypotheses and, possibly, pragmatic trials. However, these observations cannot provide better understanding of pathophysiology or even the determinants of CPPOpt. Second, we have a mechanistic approach to indirect assessment of global cerebrovascular behavior using electrical analog models of CA control pathways, feedback loops, and arterial network structure (2, 3, 7, 11–20). Here, in silico evidence is rationalized according to the fluid dynamics or electronics of inputs and outputs. In 1988, Ursino (11, 12) proposed the first “lumped compartmental model” of cerebral circulation physiology that included CA. Since then, the modeling mechanistic approach has been used to better understand patient data from, for example, transcranial Doppler studies of middle cerebral artery flow velocity (6, 21, 22). To date, such models have not been used to provide mechanistic insight into the questions of “What does PRx-derived CPPOpt mean?” and “What is the effect of manipulating BP, ICP and Paco2?”
In this report, we use the lumped compartmental model of brain circulation physiology and CA, with its system operating CPP, to assess PRx and calculated CPPOpt. Our aims are to simulate the physiology in severe TBI and better understand: 1) the potential strategies for targeting CPPOpt; 2) the relationship between CA and PRx; and 3) the determinants of ΔCPP.
MATERIALS AND METHODS
This experimental in silico study did not require Local Ethics Committee approval.
Lumped Compartmental Model of CA
We have implemented the model by Ursino et al (2), Ursino and Giannessi (3), Ursino (11, 12), and Ursino and Lodi (13, 14) to first test potential strategies for targeting CPPOpt. Figure 1 shows the electrical analog of our model with its four compartments that account for interactions among BP, ICP, CA, cerebral blood volume, Paco2, and CBF. Supplemental Digital Content 1 (http://links.lww.com/CCM/D992) provides more information about the model and the transient 6-hour change in BP profile (with 50 Hz sampling rate) used in the simulations (11, 14, 23). At baseline, the model operates with BP, CPP, CBF, and ICP at 100 mm Hg, 90.5 mm Hg, 12.5 mL/s (750 mL/min), and 10 mm Hg, respectively.
PRx and Estimation of CPPOpt
We have simulated changes in BP, Paco2, CA state, and ICP (by fluid injection into the cerebrospinal fluid [CSF] space). CPP is calculated from BP and ICP signals. CPPMed is the CPPMed for the whole simulation.
To compute PRx, we average BP and ICP over 10 seconds, and then use 40 consecutive time-averaged samples. Individual correlations are collated throughout the simulation. Mean CPP during each time series correlation calculation is then associated with the individual PRx. Then, the range in these mean CPP values is divided into 5 mm Hg width “bins,” and the mean PRx corresponding to each bin is plotted—hereafter called the “PRx-plot.” We use these data in another exploratory plot to calculate the minimum of the curve that defines CPPOpt (4, 7, 8, 24). The ΔCPP is also evaluated as a difference category (ΔCategory) according to previously used ranges (9).
RESULTS
Figure 1 shows the steady-state characteristics of the electrical analog model under conditions of Paco2 variation and CA gain. There is the expected dependence of CBF on CPP: for any given value in CPP, an increase in Paco2 causes the expected increase in CBF, whereas a decrease in Paco2 leads to the expected decrease in CBF (Fig. 1B). Figure 1C shows that when CA is impaired, there is more significant alteration in CBF with variation in CPP.
Potential Influencers of CPPOpt
Change in BP. We tested different BP profiles using fully intact CA and constant ICP and Paco2, 10 and 40 mm Hg, respectively. An example of the full graphical process for each “input” BP to “output” PRx-plot is shown in Figure S1 (Supplemental Digital Content 2, http://links.lww.com/CCM/E35). Figure S2 (Supplemental Digital Content 2, http://links.lww.com/CCM/E35) shows that degree and pattern of change in BP impact the PRx-plot and derivation of CPPOpt.
Figure 2 shows the effect of shifting by a fixed amount one of the BP profiles from Figure S2E (Supplemental Digital Content 2, http://links.lww.com/CCM/E35—see bold black line originating at 80 mm Hg), thereby maintaining the same BP profile but with different median BP (BPMed) during the whole simulation (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36). A shift in BPMed (Fig. 2A) has an impact on the position of the minimum in the PRx-plots (Fig. 2B) and CPPOpt (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36). A downward shift in BP profile by 10 mm Hg, from the line originating at 80 mm Hg (Fig. 2A, black line) to the line originating at 70 mm Hg, leads to a similar 10 mm Hg downward shift in CPPMed (from 71 to 61 mm Hg) and similar downward shift in CPPOpt (from 68 to 56 mm Hg) (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36). On inspecting these data with the same BP profile, BPMed or CPPMed (if ICP is at a constant level) determines the position of CPPOpt.
Change in Paco2. The impact of change in Paco2 on CPPOpt is minimal (Fig. S3, Supplemental Digital Content 2, http://links.lww.com/CCM/E35; and Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36). Alterations in Paco2 (32–48 mm Hg) lead to small changes in ICP and little impact on the position of the minimum in the PRx-plots. The increase in CPPOpt with increase in Paco2 from 32 to 48 mm Hg was 5 mm Hg (87–92 mm Hg).
Change in ICP. The effects of changes in ICP profile—when CA is intact and 40 mm Hg Paco2—on the PRx-plot show increasing shift with constantly increased ICP. When using the BP profile from Figure 2A (see red line originating at 100 mm Hg) with six constant levels in ICP, the output PRx-plots are shown (Fig. 3). For comparison, Figure S4 (Supplemental Digital Content 2, http://links.lww.com/CCM/E35), using the BP profile in Fig. S2C (Supplemental Digital Content 2, http://links.lww.com/CCM/E35), illustrates the output PRx-plots with the same constant shift in ICP). Figure 3 and Table S1 (Supplemental Digital Content 3, http://links.lww.com/CCM/E36) show that a constant shift of 10 mm Hg (from 20 to 30 mm Hg) results in a downward shift in CPPMed by 9 mm Hg (from 81 to 70 mm Hg). CPPOpt also decreases by 9 mm Hg (from 79 to 70 mm Hg). Therefore, similar to the findings in Figure 2, A and B, the position of CPPOpt is determined by constant rise in ICP level or constant change in CPP with a constant BP profile.
Figures 4 and 5 use the same BP profile to Figure S2C (see also Fig. S4, Supplemental Digital Content 2, http://links.lww.com/CCM/E35). (Table S1 [Supplemental Digital Content 3, http://links.lww.com/CCM/E36] shows for comparison the findings when using the ICP profiles in Fig. 3A with the BP profile from Fig. S2C [Supplemental Digital Content 2, http://links.lww.com/CCM/E35].) Figure 4 shows the effect of a series of peaks in ICP. (Of note, Fig. S5E [Supplemental Digital Content 2, http://links.lww.com/CCM/E35] shows that during such wave-like changes, PRx goes from a negative value to a positive value, and back to a negative value in the course of each wave in ICP.) An upward shift in peak ICP by 10 mm Hg (20–30 mm Hg) results in minimal downward shift in CPPMed by approximately 2 mm Hg (from 86 to 84 mm Hg), but CPPOpt shows an upward shift by approximately 10 mm Hg (from 63 to 73 mm Hg).
Figure 5 shows the effect of an escalation in ICP profile, with the same BP profile used in Figure 4. In this instance, an upward shift in the final peak in ICP by 10 mm Hg (20–30 mm Hg at peak) results in downward shift in CPPMed by 10 mm Hg (from 78 to 68 mm Hg), but CPPOpt exhibits a smaller downward shift (≈4 mm Hg, from 85 to 81 mm Hg) (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36).
CA and PRx
At baseline state (40 mm Hg Paco2 and 10 mm Hg ICP with consistent BP profile), change in CA gain—an indicator of impairment of feedback systems—has minimal consequence on the position of the minimum in the PRx-plots (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36). The increase in CPPOpt with increasingly impaired CA from 0% to 50% was small (≈2 mm Hg, from 89 to 91 mm Hg). However, mean PRx at CPPOpt changes –0.14 to 0.25, to 0.80 with increase in CA impairment from 0% to 25%, to 50%, respectively.
On inspection of Table S1 (Supplemental Digital Content 3, http://links.lww.com/CCM/E36), it is also evident that in simulations with fully intact CA, it is still possible to obtain a positive mean PRx at so-called CPPOpt; that is, a positive coefficient is not necessarily an indicator of impaired CA. (Fig. S6 [Supplemental Digital Content 2, http://links.lww.com/CCM/E35] summarizes the findings of a full analysis with 756 separate simulations, which comes to the same conclusion as Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36.)
The Determinants of ΔCPP
A fixed change in BP (Fig. 2A) or a constant rise in ICP (Fig. 3A), using the same BP profile, resulted in ΔCPP values in the ΔCategory 0–5 mm Hg (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36). We could only simulate a state with ΔCategory 5–10 mm Hg when selecting a lower BP profile (with constant ICP 10 mm Hg), and CPPMed approximately 61 mm Hg. We could simulate ΔCPP –19.9 mm Hg if we used a different BP profile (Fig. S2C, Supplemental Digital Content 2, http://links.lww.com/CCM/E35) and constantly raised ICP of 25 mm Hg.
In the simulations with serial peaks in ICP (20–35 mm Hg; Fig. 4), the ΔCategory was consistently greater than 10 mm Hg (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36). Last, an escalating rise in ICP (Fig. 5) with peak 15–25 mm Hg resulted in ΔCategory –10 to –5 mm Hg. An escalating ICP peak 30–35 mm Hg resulted in ΔCategory less than –10 mm Hg (Table S1, Supplemental Digital Content 3, http://links.lww.com/CCM/E36).
DISCUSSION
PRx-derived CPPOpt, with calculation of ΔCPP and ΔCategory, are statistical constructs and have proven value in patient risk stratification and in epidemiologic association with poor outcome (4, 7–9, 23–26). However, CPP is not physiologically controlled in homeostasis; there is no sensor, error signal, set point, or optimum within the operating range between the upper and lower limits of CA. Hence, CPPOpt-guided management may be a testable pragmatic therapeutic approach, but, intrinsically, empiricism has limitations to understanding mechanistic functions (27). How could a mechanistic model of cerebrovascular pathophysiology improve on an empirical approach that is already able to predict outcome during real-time monitoring of BP and ICP in severe TBI? In this report, we describe three insights. First, in regard to targeting CPPOpt, a shift in BPMean or mean ICP, with intact CA, impacts CPPOpt. Second, a positive PRx at CPPOpt, which should signify impaired CA, in the lumped model also occurs with intact CA. Last, in relation to ΔCPP, the compartmental model confirms that greater deviation from zero is associated with more severe 6-hour profiles in ICP.
We should first note potential limitations in our simulations. Our model simplifies a complex system. We could add more feedback systems, but have settled on the balance between complexity and the ability to model a system, which is an approach now commonly used in so-called “personalized, model-based critical care medicine” (28). Other limitations of the model are that CBF is derived without accounting for changes in cerebral metabolism, the effects of medications or CSF diversion on cerebrovascular dynamics, and the consequence of surgical interventions (e.g., craniotomy, hematoma evacuation). Neither does the model account for brain heterogeneity in CA and microvascular nonnutritive phenomena such as shunt flow (29). That said, there are four advantages of our in silico testing: 1) “ground truth” CA is known and model parameters can be set to desired values; 2) changes in BP and ICP can be controlled and examined; 3) confounding factors can be controlled or eliminated; and 4) measurement errors can be removed as noise level can be controlled.
Potential Strategies for Targeting CPPOpt
Our first finding about strategies in targeting CPPOpt when CA is intact found that shift in either BP or ICP has an impact on CPPOpt. CPPOpt is also sensitive to the low-frequency characteristics of the BP and ICP profiles. Because CPP is a derived variable and mathematically coupled to both BP and ICP, we show in a separate mathematical analysis that CPPOpt can change just by changing the input BP or ICP profiles, which confirms the findings in our simulations (Supplemental Digital Content 4, http://links.lww.com/CCM/E37). The equations also show that even when PRx does not change substantially, there can be significant change in CPPOpt. These features may explain why PRx-derived CPPOpt has applications in pediatric severe TBI even though children have lower BP (10, 30). Returning to adult severe TBI, a recent analysis of CPPOpt in 104 patients managed in two European centers found heterogeneity in CPPOpt between the centers, which was attributed to different management protocols, especially different CPP targets, and different demographic factors like age-related BPMean (31). Our report provides in silico and mathematical underpinnings for these expected observations and an explanation as to how these factors should be considered in practice.
CA and PRx
In theory, a positive PRx should be associated with impaired CA, whereas negative values should reflect intact CA. In our simulations, we found that even when CA is fully intact, it is possible to obtain a positive mean PRx at the value of CPPOpt, which is at odds with the pressure reactivity concept. In the mathematical analysis (Supplemental Digital Content 4, http://links.lww.com/CCM/E37), the equations confirm that impairment of CA will have an impact on PRx, but no major difference in ΔCPP, which in our simulations remained within ±5 mm Hg (see below). That said, under controlled conditions, in which impairment in CA is known to be present, more positive PRx does reflect more severe impairment. However, when using only ICP, BP, and CPP data, we cannot always know whether CA is impaired or not. Hence, taken in isolation, monitoring PRx is not providing added information about CA.
ΔCategory and Outcome
Several clinical studies have used the PRx-based estimate of CPPOpt (4, 7–10, 24–26) with some adult patient cohorts demonstrating an association between outcome after severe TBI and ΔCategory (9, 25). In a case series of 299 adults with severe TBI, Aries et al (8) found the following: when their summary of ΔCategory for the whole period of ICP monitoring (using a moving window of 4 hr over and average of 4 d of data) was less than –10 mm Hg, all patients died; when their summary ΔCategory was greater than 10 mm Hg, approximately 30% survived with favorable outcome, approximately 60% survived with severe disability, and the remainder died. Our simulations add to the face validity of these associations and also provide further insight. They show that during constant decrease in BP or nonextreme constant increase in ICP, shift in CPPOpt is similar to shift in CPPMed, and so the ΔCPP remains within ±5 mm Hg. The mathematical handling (Supplemental Digital Content 4, http://links.lww.com/CCM/E37) also indicates that even when CA impairment has an impact on PRx, there may not be a major change in ΔCPP, which in our simulations also remained within ±5 mm Hg. In order to generate a ΔCategory more typical of those associated with poor outcomes in the clinical literature (8, 25), our simulations needed to incorporate a major abnormality in ICP 6-hour profile. A constant ICP at 25 mm Hg or escalation in ICP without remission to greater than 30 mm Hg gave ΔCategory less than –10 mm Hg. A series of peaks in ICP up to 20–35 mm Hg resulted in ΔCategory greater than 10 mm Hg.
CONCLUSIONS
Taken together, our simulations provide mechanistic insight into the interpretation of PRx, CPPOpt, and ΔCategory. These empirically derived variables do provide a numerical summary of complex states involving well-described clinical progression and deterioration with raised ICP (32). This feature has epidemiologic importance, and we also wonder whether these composite indices may serve to provide a threshold for shift in treatment paradigm when managing cases with severe TBI—such as moving from medical to surgical interventions. Last, as illustrated by this report, the value of empirical and model-based mechanistic approaches in critical care medicine should be considered as complementary and potentially synergistic (27).
Supplementary Material
Footnotes
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Supported, in part, by a Trailblazer award from the Department of Anesthesiology, Critical Care and Pain Medicine, at Boston Children’s Hospital, Boston, MA.
Dr. Akhondi-Asl received other support from a Trailblazer Award. Dr. Tasker received funding from a “Trailblazer Award” from the Department of Anesthesiology, Perioperative and Pain Medicine, at Boston Children’s Hospital, Boston, MA. The remaining authors have disclosed that they do not have any potential conflicts of interest.
REFERENCES
- 1.Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959; 39:183–238. [DOI] [PubMed] [Google Scholar]
- 2.Ursino M, Di Giammarco P, Belardinelli E. A mathematical model of cerebral blood flow chemical regulation–Part I: Diffusion processes. IEEE Trans Biomed Eng 1989; 36:183–191. [DOI] [PubMed] [Google Scholar]
- 3.Ursino M, Giannessi M. A model of cerebrovascular reactivity including the circle of Willis and cortical anastomoses. Ann Biomed Eng 2010; 38:955–974. [DOI] [PubMed] [Google Scholar]
- 4.Czosnyka M, Smielewski P, Kirkpatrick P, et al. Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery 1997; 41:11–17. [DOI] [PubMed] [Google Scholar]
- 5.Panerai RB, Chacon M, Pereira R, et al. Neural network modelling of dynamic cerebral autoregulation: Assessment and comparison with established methods. Med Eng Phys 2004; 26:43–52. [DOI] [PubMed] [Google Scholar]
- 6.Payne S. Cerebral Autoregulation: Control of Blood Flow in the Brain. 2016Berlin, Germany, Springer. [Google Scholar]
- 7.Steiner LA, Czosnyka M, Piechnik SK, et al. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med 2002; 30:733–738. [DOI] [PubMed] [Google Scholar]
- 8.Aries MJ, Czosnyka M, Budohoski KP, et al. Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury. Crit Care Med 2012; 40:2456–2463. [DOI] [PubMed] [Google Scholar]
- 9.Lazaridis C, Smielewski P, Steiner LA, et al. Optimal cerebral perfusion pressure: Are we ready for it? Neurol Res 2013; 35:138–148. [DOI] [PubMed] [Google Scholar]
- 10.Lewis PM, Czosnyka M, Carter BG, et al. Cerebrovascular pressure reactivity in children with traumatic brain injury. Pediatr Crit Care Med 2015; 16:739–749. [DOI] [PubMed] [Google Scholar]
- 11.Ursino M. A mathematical study of human intracranial hydrodynamics. Part 1–The cerebrospinal fluid pulse pressure. Ann Biomed Eng 1988; 16:379–401. [DOI] [PubMed] [Google Scholar]
- 12.Ursino M. A mathematical study of human intracranial hydrodynamics part 2—Simulation of clinical tests. Ann Biomed Eng 1988; 16:403–416. [DOI] [PubMed] [Google Scholar]
- 13.Ursino M, Lodi CA. A simple mathematical model of the interaction between intracranial pressure and cerebral hemodynamics. J Appl Physiol (1985) 1997; 82:1256–1269. [DOI] [PubMed] [Google Scholar]
- 14.Ursino M, Lodi CA. Interaction among autoregulation, CO2 reactivity, and intracranial pressure: A mathematical model. Am J Physiol 1998; 274:H1715–H1728. [DOI] [PubMed] [Google Scholar]
- 15.Piechnik S, Czosnyka M, Smielewski P, et al. Indices for decreased cerebral blood flow control–A modelling study. Acta Neurochir Suppl 1998; 71:269–271. [DOI] [PubMed] [Google Scholar]
- 16.Banaji M, Tachtsidis I, Delpy D, et al. A physiological model of cerebral blood flow control. Math Biosci 2005; 194:125–173. [DOI] [PubMed] [Google Scholar]
- 17.Payne S. A model of the interaction between autoregulation and neural activation in the brain. Math Biosci 2006; 204:260–281. [DOI] [PubMed] [Google Scholar]
- 18.Spronck B, Martens EG, Gommer ED, et al. A lumped parameter model of cerebral blood flow control combining cerebral autoregulation and neurovascular coupling. Am J Physiol Heart Circ Physiol 2012; 303:H1143–H1153. [DOI] [PubMed] [Google Scholar]
- 19.Hu X, Nenov V, Bergsneider M, et al. Estimation of hidden state variables of the intracranial system using constrained nonlinear Kalman filters. IEEE Trans Biomed Eng 2007; 54:597–610. [DOI] [PubMed] [Google Scholar]
- 20.Silvani A, Magosso E, Bastianini S, et al. Mathematical modeling of cardiovascular coupling: Central autonomic commands and baroreflex control. Auton Neurosci 2011; 162:66–71. [DOI] [PubMed] [Google Scholar]
- 21.Ursino M, Giulioni M. Quantitative assessment of cerebral autoregulation from transcranial Doppler pulsatility: A computer simulation study. Med Eng Phys 2003; 25:655–666. [DOI] [PubMed] [Google Scholar]
- 22.Aoi MC, Kelley C, Novak V, et al. Optimization of a mathematical model of cerebral autoregulation using patient data. IFAC Proc Vol 2009; 42:181–186. [Google Scholar]
- 23.Alastruey J, Parker K, Peiró J, et al. Lumped parameter outflow models for 1-D blood flow simulations: Effect on pulse waves and parameter estimation. Commun Comput Phys 2008; 4:317–336. [Google Scholar]
- 24.Bijlenga P, Czosnyka M, Budohoski KP, et al. “Optimal cerebral perfusion pressure” in poor grade patients after subarachnoid hemorrhage. Neurocrit Care 2010; 13:17–23. [DOI] [PubMed] [Google Scholar]
- 25.Zweifel C, Lavinio A, Steiner LA, et al. Continuous monitoring of cerebrovascular pressure reactivity in patients with head injury. Neurosurg Focus 2008; 25:E2. [DOI] [PubMed] [Google Scholar]
- 26.Petkus V, Krakauskaitė S, Preikšaitis A, et al. Association between the outcome of traumatic brain injury patients and cerebrovascular autoregulation, cerebral perfusion pressure, age, and injury grades. Medicina (Kaunas) 2016; 52:46–53. [DOI] [PubMed] [Google Scholar]
- 27.Baker RE, Pena J-M, Jayamohan J, et al. Mechanistic models versus machine learning, a fight worth fighting for the biological community? Biol Lett 2018; 14:20170660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Chase JG, Preiser JC, Dickson JL, et al. Next-generation, personalised, model-based critical care medicine: A state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them. Biomed Eng Online 2018; 17:24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Dai X, Bragina O, Zhang T, et al. High intracranial pressure induced injury in the healthy rat brain. Crit Care Med 2016; 44:e633–e638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Young AM, Donnelly J, Czosnyka M, et al. Continuous multimodality monitoring in children after traumatic brain injury-preliminary experience. PLoS One 2016; 11:e0148817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Howells T, Smielewski P, Donnelly J, et al. Optimal cerebral perfusion pressure in centers with different treatment protocols. Crit Care Med 2018; 46:e235–e241. [DOI] [PubMed] [Google Scholar]
- 32.Lundberg N. Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psychiatr Scand Suppl 1960; 36:1–193. [PubMed] [Google Scholar]